Publications found:
36,694
Sort by:
2018 Eosinophilic Esophagitis Drug Development- Pipeline Analysis Report
US$ 899.00
... 15 companies and universities are focusing on developing treatment options for Eosinophilic Esophagitis. To assist investigators and funding and regulatory ... entities, recent developments, orphan drug/fast track/other designations, drug class are provided for each Eosinophilic Esophagitis pipeline product. ...
May 2018
-
2018 Exocrine Pancreatic Insufficiency Drug Development- Pipeline Analysis Report
US$ 899.00
... universities are focusing on developing treatment options for Exocrine Pancreatic Insufficiency. To assist investigators and funding and regulatory organizations ... developments, orphan drug/fast track/other designations, drug class are provided for each Exocrine Pancreatic Insufficiency pipeline product. ...
May 2018
-
2018 Gastritis (stomach inflammation) Drug Development- Pipeline Analysis Report
US$ 899.00
Gastritis is the inflammation of mucosa, lining of stomach, that can last for shorter periods or longer durations. Infection, alcohol and intake of NSAIDs lead to gastritis. ... /IND, pre registration, phase 1, phase 2, and phase 3 trials). Drugs under development directly and through combination with other ...
May 2018
-
2018 Gastroesophageal Reflux Disease (GERD) Drug Development- Pipeline Analysis Report
US$ 899.00
... Gastroesophageal Reflux Disease (GERD). To assist investigators and funding and regulatory organizations, VPA Research has come up with a comprehensive report on Gastroesophageal Reflux Disease (GERD ... the report provides key trends in Gastroesophageal Reflux Disease (GERD) pipeline studies. The products under ...
May 2018
-
2018 Hepatic Encephalopathy Drug Development- Pipeline Analysis Report
US$ 899.00
... billion market in the US alone, Hepatic Encephalopathy is a GI disorder affecting around 2 million people in the country. Hepatic Encephalopathy (HE) is a neuropsychiatric syndrome with ... recent developments, orphan drug/fast track/other designations, drug class are provided for each Hepatic Encephaopathy ...
May 2018
-
2018 Hepatic Insufficiency Drug Development- Pipeline Analysis Report
US$ 899.00
... 30 companies and universities are focusing on developing treatment options for Liver Failure (Hepatic Insufficiency). To assist investigators and funding and ... , recent developments, orphan drug/fast track/other designations, drug class are provided for each Liver Failure (Hepatic Insufficiency) pipeline product ...
May 2018
-
2018 Liver Cirrhosis Drug Development- Pipeline Analysis Report
US$ 899.00
... Over 20 companies and universities are focusing on developing treatment options for Liver Cirrhosis. To assist investigators and funding and regulatory organizations ... and entities, recent developments, orphan drug/fast track/other designations, drug class are provided for each Liver Cirrhosis pipeline product. ...
May 2018
-
2018 Liver Failure Drug Development- Pipeline Analysis Report
US$ 899.00
... Over 30 companies and universities are focusing on developing treatment options for Liver Failure (Hepatic Insufficiency). To assist investigators and funding ... and entities, recent developments, orphan drug/fast track/other designations, drug class are provided for each Liver Failure (Hepatic Insufficiency) ...
May 2018
-
2018 Opioid Induced Constipation (OIC) Drug Development- Pipeline Analysis Report
US$ 899.00
... Opioid Induced Constipation (OIC). To assist investigators and funding and regulatory organizations, VPA Research has come up with a comprehensive report on Opioid Induced Constipation (OIC ... , the report provides key trends in Opioid Induced Constipation (OIC) pipeline studies. The products under development ...
May 2018
-
2018 Oral Mucositis Drug Development- Pipeline Analysis Report
US$ 899.00
... Over 30 companies and universities are focusing on developing treatment options for Oral Mucositis. To assist investigators and funding and regulatory organizations ... and entities, recent developments, orphan drug/fast track/other designations, drug class are provided for each Oral Mucositis pipeline product. ...
May 2018
-
2018 Peptic Ulcers Drug Development- Pipeline Analysis Report
US$ 899.00
... Over 20 companies and universities are focusing on developing treatment options for Peptic Ulcers. To assist investigators and funding and regulatory ... and entities, recent developments, orphan drug/fast track/other designations, drug class are provided for each Peptic Ulcers pipeline product. Mechanism ...
May 2018
-
2018 Post Operative Nausea And Vomiting Drug Development- Pipeline Analysis Report
US$ 899.00
... companies and universities are focusing on developing treatment options for Post Operative Nausea and Vomiting. To assist investigators and funding and regulatory ... , VPA Research has come up with a comprehensive report on Post Operative Nausea and Vomiting pipeline. The report provides insights into different ...
May 2018
-
2018 Primary biliary cirrhosis Drug Development- Pipeline Analysis Report
US$ 899.00
... and universities are focusing on developing treatment options for Primary biliary cirrhosis. To assist investigators and funding and regulatory organizations, ... recent developments, orphan drug/fast track/other designations, drug class are provided for each Primary biliary cirrhosis pipeline product. Mechanism ...
May 2018
-
2018 Primary billary cholangitis Drug Development- Pipeline Analysis Report
US$ 899.00
... universities are focusing on developing treatment options for Primary billary cholangitis. To assist investigators and funding and regulatory organizations ... recent developments, orphan drug/fast track/other designations, drug class are provided for each Primary billary cholangitis pipeline product. Mechanism ...
May 2018
-
2018 Primary Sclerosing Cholangitis Drug Development- Pipeline Analysis Report
US$ 899.00
... universities are focusing on developing treatment options for Primary sclerosing cholangitis. To assist investigators and funding and regulatory organizations ... developments, orphan drug/fast track/other designations, drug class are provided for each Primary sclerosing cholangitis pipeline product. Mechanism ...
May 2018
-
2018 Reflux Esophagitis/GERD Drug Development- Pipeline Analysis Report
US$ 899.00
... Around 30 companies and universities are focusing on developing treatment options for Reflux Esophagitis/GERD. To assist investigators and funding and regulatory ... entities, recent developments, orphan drug/fast track/other designations, drug class are provided for each Reflux Esophagitis/GERD pipeline product. ...
May 2018
-
2018 Short Bowel Syndrome Drug Development- Pipeline Analysis Report
US$ 899.00
... and universities are focusing on developing treatment options for Short Bowel Syndrome. To assist investigators and funding and regulatory organizations, ... , recent developments, orphan drug/fast track/other designations, drug class are provided for each Short Bowel Syndrome pipeline product. Mechanism of ...
May 2018
-
2018 Systemic Mastocytosis Drug Development- Pipeline Analysis Report
US$ 899.00
... Around 15 companies and universities are focusing on developing treatment options for Systemic Mastocytosis. To assist investigators and funding and regulatory ... and entities, recent developments, orphan drug/fast track/other designations, drug class are provided for each Systemic Mastocytosis pipeline product. ...
May 2018
-
2018 Traveler’s Diarrhea Drug Development- Pipeline Analysis Report
US$ 899.00
... Around 10 companies and universities are focusing on developing treatment options for Traveler's Diarrhea. To assist investigators and funding and regulatory ... and entities, recent developments, orphan drug/fast track/other designations, drug class are provided for each Traveler's Diarrhea pipeline product. ...
May 2018
-
Global Sickle Cell Anemia Drug Market, Price, Dosage & Clinical Pipeline Outlook 2024
US$ 2,400.00
... & Sales Analysis of Key Drugs Global Sickle Cell Anemia Drug Clinical Pipeline by Company & Phase Global Sickle Cell Anemia Drug Clinical Pipeline: 40 Drugs Marketed Sickle Cell Anemia Drugs: 4 Drugs Future Aspects of Global Sickle Cell Disease Treatment Market Sickle cell anemia is a blood disorder widely ...
May 2018
170 pages
Intravenous (IV) Iron Drugs: Market Research Report
US$ 5,600.00
This report analyzes the worldwide markets for Intravenous (IV) Iron Drugs in US$ Thousand. The report provides separate comprehensive analytics for the US, ... 2024. Also, a five-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary ...
April 2018
165 pages
Insulin Pumps (External): Market Research Report
US$ 5,450.00
This report analyzes the worldwide markets for Insulin Pumps (External) in US$ Thousand. The report provides separate comprehensive analytics for the US, ... 2022. Also, a six-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary ...
April 2018
205 pages
Herbal Supplements and Remedies: Market Research Report
US$ 5,600.00
This report analyzes the worldwide markets for Herbal Supplements and Remedies in US$ by the following Product Segments: Ginkgo Biloba, Garlic, Ginseng, Echinacea, ... , Aloe Vera, Specialty Herbs, Multi-Herbs, and Other Herbal Supplements. The report provides separate comprehensive analytics for the US, Canada ...
April 2018
371 pages
2018 U.S. Drugs and Druggists' Sundries Wholesales-Industry and Market Report
US$ 149.00
The 2018 U.S. Drugs and Druggists' Sundries ... 2018 current and 2019 forecast estimates on the size of the industry (sales, establishments, employment) nationally and for all 50 U.S. States ... sub-industries, including special line drugs and general line drugs. This industry comprises establishments primarily ...
April 2018
195 pages
2018 Alcoholic Hepatitis Drug Development- Pipeline Analysis Report
US$ 899.00
... and universities are focusing on developing treatment options for Alcoholic Hepatitis. To assist researchers and business development managers, VPA Research has ... entities, recent developments, orphan drug/fast track/other designations, drug class are provided for each Alcoholic Hepatitis pipeline product. ...
April 2018
-
2018 Atrial Fibrillation Drug Development- Pipeline Analysis Report
US$ 899.00
... and universities are focusing on developing treatment options for Atrial Fibrillation. To assist researchers and business development managers, VPA Research has ... entities, recent developments, orphan drug/fast track/other designations, drug class are provided for each Atrial Fibrillation pipeline product. ...
April 2018
-
2018 Community- Acquired Pneumonia (CAP) Drug Development- Pipeline Analysis Report
US$ 899.00
... myalgia, arthralgia are key symptoms. Community Acquired Pneumonia pipeline comprises of 16 drugs under active development as of April 2018. Of these, 3 drugs are ... has come up with a comprehensive report on Community Acquired Pneumonia (CAP) pipeline. The report provides insights into different therapeutic ...
April 2018
-
2018 Critical Limb Ischemia (CLI) Drug Development- Pipeline Analysis Report
US$ 899.00
... Critical Limb Ischemia worldwide, with an estimated market size of $10 to $12 billion. Critical Limb Ischemia pipeline comprises of 27 active drugs under active development as of April 2018 ... come up with a comprehensive report on Critical Limb Ischemia (CLI) pipeline. The report provides insights into ...
April 2018
-
2018 hepatitis C Drug Development- Pipeline Analysis Report
US$ 899.00
... no vaccine is available against HCV. Due to the mutations in Hepatitis C virus, development of a prophylactic vaccine is highly challenging. The condition is classified ... and entities, recent developments, orphan drug/fast track/other designations, drug class are provided for each Hepatitis C (HCV) pipeline ...
April 2018
-
Global Respiratory Drugs Pipeline Analysis Market 2018
US$ 3,500.00
Respiratory Drugs Pipeline Analysis Overview: Pulmonary medicine is the branch of medical science that deals with diagnosis, prevention, and treatment of diseases affecting the respiratory system. Respiratory drugs finds ...
April 2018
188 pages
Beta Nerve Growth Factor (Beta NGF or NGF) - Pipeline Review, H1 2018
US$ 3,500.00
... Beta Nerve Growth Factor (Beta NGF or NGF) targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industry-specific sources The report covers pipeline products ...
April 2018
52 pages
Transforming Growth Factor Beta 1 (TGFB1) - Pipeline Review, H1 2018
US$ 3,500.00
... Transforming Growth Factor Beta 1 (TGFB1) targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industry-specific sources The report covers pipeline products ...
April 2018
69 pages
